Metraipolis › archive › dc_48d32edbc676
The why and how of the SynNerGe criteria of Parkinson´s disease — Europe PMC PMID:38916622
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/38916622
- DOI
- 10.1007/s00702-[numero omesso]-9
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-06T10:24:02.825Z
- SHA-256 of the archived text
8ca31fa8a02da8b70c61c38862bb9ee48afcefa8f278e5c286cf964dcce63068- Stable URL of this page
https://metraipolis.com/documento/dc_48d32edbc676
How to cite
The why and how of the SynNerGe criteria of Parkinson´s disease — Europe PMC PMID:38916622 — Europe PMC (en), https://europepmc.org/article/MED/38916622 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_48d32edbc676 (Metraipolis archive dc_48d32edbc676, sha256 8ca31fa8a02da8b70c61c38862bb9ee48afcefa8f278e5c286cf964dcce63068)
BibTeX
@misc{dc48d32edbc676,
title = {The why and how of the SynNerGe criteria of Parkinson´s disease — Europe PMC PMID:38916622},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/38916622},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_48d32edbc676; sha256 8ca31fa8a02da8b70c61c38862bb9ee48afcefa8f278e5c286cf964dcce63068},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/38916622. Agents can read the archived copy with the MCP tool read_document.